Raymond James Financial’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.7M Buy
705,834
+328,222
+87% +$15.7M 0.01% 1120
2026
Q1
$15.8M Buy
377,612
+263,515
+231% +$11.4M ﹤0.01% 1638
2025
Q4
$4.58M Buy
114,097
+18,440
+19% +$731K ﹤0.01% 2583
2025
Q3
$3.78M Buy
95,657
+65,523
+217% +$2.42M ﹤0.01% 2681
2025
Q2
$1.12M Buy
+30,134
New +$1.02M ﹤0.01% 3499

Other funds holding CPAI

Raymond James Financial's CPAI Position: Q2 2026 in Review

Raymond James Financial increased its Counterpoint Quantitative Equity ETF (CPAI) stake by 87% in Q2 2026, buying an estimated $15.7M and bringing the position to 705,834 shares worth $36.7M. The position accounts for 0.01% of the portfolio, ranked #1120.

Raymond James Financial first reported a position in CPAI in Q2 2025 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold CPAI as of Q2 2026.

  • Raymond James Financial held 705,834 shares of Counterpoint Quantitative Equity ETF worth $36.7M as of Q2 2026.
  • Raymond James Financial bought 328,222 Counterpoint Quantitative Equity ETF shares in Q2 2026, an estimated $15.7M.
  • Counterpoint Quantitative Equity ETF made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1120 holding.
  • Raymond James Financial first reported a position in Counterpoint Quantitative Equity ETF in Q2 2025 and has held it in 5 quarters since.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.